TissueLabs, a Swiss firm specializing in biofabrication applied sciences, has launched TissuePro, a brand new extrusion-based bioprinter designed for superior purposes in regenerative drugs, drug improvement, and associated fields. The discharge builds on the success of the corporate’s earlier system, TissueStart, which turned a broadly used entry-level platform for labs exploring tissue engineering.
“TissuePro is the results of the whole lot we’ve realized, reinvented and reimagined,” mentioned Dr. Gabriel Liguori, Founder and CEO of TissueLabs. TissuePro is at present accessible for pre-order, with deliveries scheduled to start in August 2025.
TissuePro options 5 unbiased piston-driven extruders, every able to allotting with 0.1 μL precision. In contrast to pressure-based extrusion programs, piston-based extrusion minimizes the necessity for ongoing calibration, permitting customers to deal with designing and producing complicated organic constructions.
The platform additionally integrates Mixtrusor, TissueLabs’ proprietary mixing module, which helps simultaneous extrusion of a number of bioinks, enabling the fabrication of heterogeneous tissues with managed gradients and layered compositions.
The system helps multi-material printing with 5 unbiased printheads, together with coaxial and triaxial capabilities. It additionally features a built-in photocuring module with 5 wavelength choices (365nm, 405nm, 450nm, 530nm, and 810nm) to accommodate totally different materials formulations. The printheads and printbed supply thermal management from 4°C to 60°C, permitting a variety of supplies to be processed beneath constant situations.
Automation instruments are included to coordinate multi-head operations, simplifying workflows that sometimes require handbook setup. TissueLabs positions the system as each high-performance and user-friendly, aiming to help researchers throughout disciplines equivalent to tissue engineering, most cancers analysis, organ-on-a-chip improvement, comfortable robotics, cultured meat, and pharmaceutical testing.